Progressive release of vitreomacular traction with aflibercept

Research output: Contribution to journalArticle

Abstract

A patient with combined diabetic macular edema (DME) and vitreomacular traction (VMT) was treated with a series of intravitreal aflibercept (Eylea; Regeneron, Tarrytown, NY) injections. The VMT progressively released during the course of the five intravitreal injections. This release may have been spontaneous, due to a nonspecific mechanical effect from the injections, or due to a pharmacologic effect from the aflibercept. While treating DME, anti-vascular endothelial growth factor agents may have an additional benefit in releasing VMT.

Original languageEnglish (US)
Pages (from-to)477-481
Number of pages5
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume47
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Traction
Macular Edema
Intravitreal Injections
Injections
Vascular Endothelial Growth Factor A
aflibercept

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Cite this

Progressive release of vitreomacular traction with aflibercept. / Schwartz, Stephen; Flynn, Harry W.

In: Ophthalmic Surgery Lasers and Imaging Retina, Vol. 47, No. 5, 01.05.2016, p. 477-481.

Research output: Contribution to journalArticle

@article{cde73458894946f0a47b33d74ba02cf5,
title = "Progressive release of vitreomacular traction with aflibercept",
abstract = "A patient with combined diabetic macular edema (DME) and vitreomacular traction (VMT) was treated with a series of intravitreal aflibercept (Eylea; Regeneron, Tarrytown, NY) injections. The VMT progressively released during the course of the five intravitreal injections. This release may have been spontaneous, due to a nonspecific mechanical effect from the injections, or due to a pharmacologic effect from the aflibercept. While treating DME, anti-vascular endothelial growth factor agents may have an additional benefit in releasing VMT.",
author = "Stephen Schwartz and Flynn, {Harry W}",
year = "2016",
month = "5",
day = "1",
doi = "10.3928/23258160-20160419-13",
language = "English (US)",
volume = "47",
pages = "477--481",
journal = "Ophthalmic Surgery Lasers and Imaging Retina",
issn = "2325-8160",
publisher = "Slack Incorporated",
number = "5",

}

TY - JOUR

T1 - Progressive release of vitreomacular traction with aflibercept

AU - Schwartz, Stephen

AU - Flynn, Harry W

PY - 2016/5/1

Y1 - 2016/5/1

N2 - A patient with combined diabetic macular edema (DME) and vitreomacular traction (VMT) was treated with a series of intravitreal aflibercept (Eylea; Regeneron, Tarrytown, NY) injections. The VMT progressively released during the course of the five intravitreal injections. This release may have been spontaneous, due to a nonspecific mechanical effect from the injections, or due to a pharmacologic effect from the aflibercept. While treating DME, anti-vascular endothelial growth factor agents may have an additional benefit in releasing VMT.

AB - A patient with combined diabetic macular edema (DME) and vitreomacular traction (VMT) was treated with a series of intravitreal aflibercept (Eylea; Regeneron, Tarrytown, NY) injections. The VMT progressively released during the course of the five intravitreal injections. This release may have been spontaneous, due to a nonspecific mechanical effect from the injections, or due to a pharmacologic effect from the aflibercept. While treating DME, anti-vascular endothelial growth factor agents may have an additional benefit in releasing VMT.

UR - http://www.scopus.com/inward/record.url?scp=84983376930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983376930&partnerID=8YFLogxK

U2 - 10.3928/23258160-20160419-13

DO - 10.3928/23258160-20160419-13

M3 - Article

C2 - 27183554

AN - SCOPUS:84983376930

VL - 47

SP - 477

EP - 481

JO - Ophthalmic Surgery Lasers and Imaging Retina

JF - Ophthalmic Surgery Lasers and Imaging Retina

SN - 2325-8160

IS - 5

ER -